30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Robert Rosenthal

Performance

Overall performance
2.8

Performance over holding periods
2.8
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 5% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Director MZT Holdings Inc Jan. 22, 2007 -
Director InVivo Therapeutics Holdings Corp Nov. 12, 2019 -
Executive Chairman of the Board, Principal Executive Officer Safeguard Scientifics Inc April 1, 2020 -
Independent Director Bruker Corp Nov. 11, 2015 -
Independent Chairman of the Board Safeguard Scientifics Inc May 19, 2016 - April 1, 2020
Independent Director Safeguard Scientifics Inc July 26, 2007 - May 19, 2016

Robert Rosenthal's trades of Bruker Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-08-16 2024-08-15 S Sale
4,152 +12.9%
302.70
US$3,363,573
4,152 +12.9% 302.70 US$3,363,573
2024-08-15 2024-08-15 PrS Proposed sale
95,847
378.70
US$4,136,604
95,847 378.70 US$4,136,604
2020-05-12 2020-05-11 B Purchase
9,766 -33.5%
209.62
US$502,164
9,766 -33.5% 209.62 US$502,164